You are on page 1of 300

NOTE : ADD YOUR REGION AND DELETE OTHER REGION ROWS ADD AMT IN "K"(Thousand)

Budget Actual Sales


Sr.No Zone Region Division (Nov'22 to (Nov'22 to
Oct'23) Sep'23)

BIHAR / L ALL DIV


1 EAST1 NE / L ALL DIV
WB / L ALL DIV
DEL1 / L ALL DIV
2 NORTH1 / L PJB / L ALL DIV
RAJ / L ALL DIV
MP / L ALL DIV
3 NORTH2 / L UP 1 / L ALL DIV
UP 2 / L ALL DIV
AP / L ALL DIV
KARN / L ALL DIV
TELG / L ALL DIV
4 SOUTH1,2 / L
KRL 1 / L ALL DIV
TN1 / L ALL DIV
TN2 / L ALL DIV
GUJ1 / L ALL DIV
MAH1 / L ALL DIV
5 WEST1 / L
MAH2 / L ALL DIV
MUM / L ALL DIV

AMT IN "K"(Thousand)

Budget Actual Sales


Sr.No Zone Region Division (Nov'22 to (Nov'22 to
Oct'23) Sep'23)

PDP (10) 0 0
COG R ( 20 ) 0 0
1 EAST1 ADD HERE COG INST (25 ) 0 0
EXAMPLE:
BIHAR/NE/W NPT+CL REAG(91,95) 0 0
B NPT+CL INST(92,96) 0 0
TOTAL 0 0

SALES CONTRIBUTION

SALES TREND AGAINST BUDGET ,A


1
0.9
0.8
0.7
SALES TREND AGAINST BUDGET ,A
1
0.9
0.8
0.7
0.6
0.5
0.4
0.3
0.2
0.1
0 0 0 0 0 0 0 0 0
0
PDP (10) COG R ( 20 ) COG INST (25 )

Budget (Nov'22 to Oct'23) Actual +Fc Sales (Nov'22

Budget (Nov'22 to Oct'23)

PDP (10) COG R ( 20 ) COG INST (25 )


NPT+CL REAG(91,95) NPT+CL INST(92,96)

QTY
Budget
Sr.No Zone Region Division (Nov'22 to
Oct'23) QTY
INST NAME
1 Xact Pro
AUTOCELL +
INGENIIOUS
COG INST (25 )
INCUBE
Example THROMBOSTAT
Bihar
U120
PC A1c
NPT INST
SC EL
CORELAB-Inst U500
2
Xact Pro
AUTOCELL +
COG INST (25 ) INGENIIOUS
INCUBE
Example WB
THROMBOSTAT
U120
PC A1c
NPT INST
SC EL
CORELAB-Inst U500
3
Xact Pro
AUTOCELL +
COG INST (25 ) INGENIIOUS
INCUBE
Example NE
THROMBOSTAT
U120
PC A1c
NPT INST
SC EL
CORELAB-Inst U500
EAST1
4 example
Xact Pro
AUTOCELL +
COG INST (25 ) INGENIIOUS
Example INCUBE
KARN THROMBOSTAT
U120
PC A1c
NPT INST
SC EL
CORELAB-Inst U500
5
Xact Pro
AUTOCELL +
COG INST (25 ) INGENIIOUS
INCUBE
Example TN
THROMBOSTAT
U120
PC A1c
NPT INST
SC EL
CORELAB-Inst U500
6
Xact Pro
AUTOCELL +
COG INST (25 ) INGENIIOUS
Example INCUBE
KRL THROMBOSTAT
U120
Example
KRL

PC A1c
NPT INST
SC EL
CORELAB-Inst U500
0
Example Xact Pro
BiharExamp AUTOCELL + 0
le COG INST (25 ) INGENIIOUS 0
WBExample INCUBE 0
Add Region
TOTAL Name here NEExample
THROMBOSTAT 0
KARNExam
ple U120 0
TNExample PC A1c 0
NPT INST
KRL SC EL 0
CORELAB-Inst U500 0
Actual +Fc Sales LY Actual Sale
Forecasted Sales
(Nov'22 (Nov'21 to
(Oct'23 )
to Oct'23) Oct'22)

d)

Actual +Fc Sales Actual Sale


Forecasted Sales
(Nov'22 (Nov'21 to
(Oct'23 )
to Oct'23) Oct'22)

0 0 0
0 0 0
0 0 0
0 0 0
0 0 0
0 0 0

REND AGAINST BUDGET ,ACT,LAST YEAR


REND AGAINST BUDGET ,ACT,LAST YEAR

0 0 0 0 0 0 0 0 0
COG INST (25 ) NPT+CL REAG(91,95) NPT+CL INST(92,96)

23) Actual +Fc Sales (Nov'22 to Oct'23) Actual Sale (Nov'21 to Oct'22)

Actual +Fc Sales (Nov'22 to Oct'23)

PDP (10) COG R ( 20 ) COG INST (25 ) NPT+CL REAG(91,95) NPT+CL INST(92,96)

Y
Actual Sales Forecasted Sales Actual +Fc Sales Actual Sale
(Nov'22 to (Oct'23 ) (Nov'22 (Nov'21 to
Sep'23) QTY QTY to Oct'23) QTY Oct'22) QTY
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
Actual
Sale
(Nov'20
to Oct'21)

Actual
Sale
(Nov'20
to Oct'21)
0 0
NST(92,96)

T(92,96)
Actual
Actual
+Fc Sales
Sale AHQ 23
(Nov'21 24
(Nov'22 to
to Oct'22)
Oct'23)

Actual
Actual
+Fc Sales
Sale AHQ 23
(Nov'21 24
(Nov'22 to
to Oct'22)
Oct'23)
NOTE : ADD YOUR REGION AND DELETE OTHER REGIO
ADD AMT IN "K"(Thousand) BUDGET 23 24

C1
Sr.No Zone Region Division AHQ 23 24 BUD Nov 23 to Feb
24

BIHAR / L ALL DIV 0


1 EAST1 NE / L ALL DIV 0
WB / L ALL DIV 0
DEL1 / L ALL DIV 0
2 NORTH1 / L PJB / L ALL DIV 0
RAJ / L ALL DIV 0
MP / L ALL DIV 0
3 NORTH2 / L UP 1 / L ALL DIV 0
UP 2 / L ALL DIV 0
AP / L ALL DIV 0
KARN / L ALL DIV 0
TELG / L ALL DIV 0
4 SOUTH1,2 / L
KRL 1 / L ALL DIV 0
TN1 / L ALL DIV 0
TN2 / L ALL DIV 0
GUJ1 / L ALL DIV 0
MAH1 / L ALL DIV 0
5 WEST1 / L
MAH2 / L ALL DIV 0
MUM / L ALL DIV 0

AMT IN "K"(Thousand) BUDGET

C1
AHQ 23 24
Sr.No Zone Region Division Nov 23 to Feb
PLAN/BUD
24

PDP (10) 0 0
COG R ( 20 ) 0 0
1 EAST1 ADD HERE COG INST (25 ) 0 0
EXAMPLE:
BIHAR/NE/W NPT+CL REAG(91,95) 0 0
B NPT+CL INST(92,96) 0 0
TOTAL 0 0
QTY
BUDGET
AHQ 23 24
Sr.No Zone Region Division INST NAME PLAN/BUD
Qty

1 0
Xact Pro
AUTOCELL + 0
COG INST (25 ) INGENIIOUS 0
Example INCUBE 0
Bihar THROMBOSTAT 0
U120 0
PC A1c 0
NPT INST
SC EL 0
CORELAB-Inst U500 0
2 0
Xact Pro
AUTOCELL + 0
COG INST (25 ) INGENIIOUS 0
INCUBE 0
Example WB
THROMBOSTAT 0
U120 0
PC A1c 0
NPT INST
SC EL 0
CORELAB-Inst U500 0
3 0
Xact Pro
AUTOCELL + 0
COG INST (25 ) INGENIIOUS 0
INCUBE 0
Example NE
THROMBOSTAT 0
U120 0
PC A1c 0
NPT INST
SC EL 0
EAST1 CORELAB-Inst U500 0
example
4 0
Xact Pro
AUTOCELL + 0
COG INST (25 ) INGENIIOUS 0
Example INCUBE 0
KARN THROMBOSTAT 0
U120 0
PC A1c 0
NPT INST
SC EL 0
CORELAB-Inst U500 0
5 0
Xact Pro
AUTOCELL + 0
COG INST (25 ) INGENIIOUS 0
INCUBE 0
Example TN
THROMBOSTAT 0
U120 0
PC A1c 0
NPT INST
SC EL 0
CORELAB-Inst U500 0
6 0
Xact Pro
AUTOCELL + 0
COG INST (25 ) INGENIIOUS 0
Example INCUBE 0
KRL THROMBOSTAT 0
U120 0
PC A1c 0
NPT INST
SC EL 0
CORELAB-Inst U500 0
0
Example Xact Pro
BiharExamp AUTOCELL + 0
le COG INST (25 ) INGENIIOUS 0
WBExample INCUBE 0
Add Region
TOTAL Name here NEExample
THROMBOSTAT 0
KARNExam
ple U120 0
TNExample PC A1c 0
NPT INST
KRL SC EL 0
CORELAB-Inst U500 0
REGION AND DELETE OTHER REGION ROWS
BUDGET 23 24 PLAN 23 24 4 Month C1

C2
C3 C1 C1 C1 C1
Mar24 to Jun
Jul24 to Oct 24 Nov 23 Dec 23 Jan 24 Feb 24
24

BUDGET PLAN 23 24 4 Month C1

C2
C3 C1 C1 C1 C1
Mar24 to Jun
Jul24 to Oct 24 Nov 23 Dec 23 Jan 23 Feb 24
24

0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
QTY
BUDGET PLAN 23 24 4 Month C1
C1 C2 C3
C1 C1 C1
Nov 23 to Feb Mar24 to Jun Jul24 to Oct 24
Nov 23 Dec 23 Jan 23
24 Qty 24 Qty Qty
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
0 0 0 0 0 0
Month C1
C1
Feb 24
0
0
0
0
0
0
0
0
0
Actual
Actual Actual
+Fc Sales
Sale Sale AHQ 23
(Nov'20 (Nov'21 24
(Nov'22 to
to Oct'21) to Oct'22)
Oct'23)

Actual
Actual Actual
+Fc Sales
Sale Sale AHQ 23
(Nov'20 (Nov'21 24
(Nov'22 to
to Oct'21) to Oct'22)
Oct'23)
Name: Zonal Manager Name
Zone: Zone Name

AUTO FILL AFTER UPDATE E

Budget Actual Sales


Sr.No Zone Division
(Nov'22 to Oct'23) (Nov'22 to Sep'23)

PDP
0.0 0.0
Cogent R
0.0 0.0
Cogent I (All)
0.0 0.0
ANDHRA
1 Cogent Total
PRADESH 0.0 0.0
PDP + Cogent(R + I)
0.0 0.0
NPT & CL ( INST +REAG)
0.0 0.0
PDP +COG(R+I)+NPT+CL
0.0 0.0

FILL FROM HERE EACH REGION


Budget Actual Sales
Sr.No Zone Division
(Nov'22 to Oct'23) (Nov'22 to Sep'23)
PDP 0.0 0.0
Cogent R 0.0 0.0
Cogent I (All) 0.0 0.0
1.1 Example AP Cogent Total 0.0 0.0
PDP + Cogent(R + I) 0.0 0.0
NPT & CL ( INST +REAG) 0.0 0.0
PDP +COG(R+I)+NPT+CL 0.0 0.0
Budget Actual Sales
Sr.No Zone Division
(Nov'22 to Oct'23) (Nov'22 to Sep'23)
PDP 0.0 0.0
Cogent R 0.0 0.0
Cogent I (All) 0.0 0.0
1.2 Example TELG Cogent Total 0.0 0.0
PDP + Cogent(R + I) 0.0 0.0
NPT & CL ( INST +REAG) 0.0 0.0
PDP +COG(R+I)+NPT+CL 0.0 0.0

Budget Actual Sales


Sr.No Zone Division
(Nov'22 to Oct'23) (Nov'22 to Sep'23)
PDP 0.0 0.0
Cogent R 0.0 0.0
Cogent I (All) 0.0 0.0
1.3 Example TN1 Cogent Total 0.0 0.0
PDP + Cogent(R + I) 0.0 0.0
NPT & CL ( INST +REAG) 0.0 0.0
PDP +COG(R+I)+NPT+CL 0.0 0.0

Budget Actual Sales


Sr.No Zone Division
(Nov'22 to Oct'23) (Nov'22 to Sep'23)
PDP 0.0 0.0
Cogent R 0.0 0.0
Cogent I (All) 0.0 0.0
1.4 Example TN2 Cogent Total 0.0 0.0
PDP + Cogent(R + I) 0.0 0.0
NPT & CL ( INST +REAG) 0.0 0.0
PDP +COG(R+I)+NPT+CL 0.0 0.0

Budget Actual Sales


Sr.No Zone Division
(Nov'22 to Oct'23) (Nov'22 to Sep'23)
PDP 0.0 0.0
Cogent R 0.0 0.0
Cogent I (All) 0.0 0.0
1.5 Example KRL Cogent Total 0.0 0.0
PDP + Cogent(R + I) 0.0 0.0
NPT & CL ( INST +REAG) 0.0 0.0
PDP +COG(R+I)+NPT+CL 0.0 0.0
Budget Actual Sales
Sr.No Zone Division
(Nov'22 to Oct'23) (Nov'22 to Sep'23)
PDP 0.0 0.0
Cogent R 0.0 0.0
Cogent I (All) 0.0 0.0
1.6 Example KARN Cogent Total 0.0 0.0
PDP + Cogent(R + I) 0.0 0.0
NPT & CL ( INST +REAG) 0.0 0.0
PDP +COG(R+I)+NPT+CL 0.0 0.0
ADD AMT IN "K" ("0000")
TER UPDATE EACH REGION
Actual +Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23 ) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)

0.0 0.0 0.0 0.0 #DIV/0!

0.0 0.0 0.0 0.0 #DIV/0!

0.0 0.0 0.0 0.0 #DIV/0!

0.0 0.0 0.0 0.0 #DIV/0!

0.0 0.0 0.0 0.0 #DIV/0!

0.0 0.0 0.0 0.0 #DIV/0!

0.0 0.0 0.0 0.0 #DIV/0!

ADD AMT IN "K" ("0000")


Actual +Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23 ) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!

ADD AMT IN "K" ("0000")


Actual +Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23 ) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!

ADD AMT IN "K" ("0000")


Actual +Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23 ) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!

ADD AMT IN "K" ("0000")


Actual +Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23 ) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!

ADD AMT IN "K" ("0000")


Actual +Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23 ) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!

ADD AMT IN "K" ("0000")


Actual +Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23 ) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!
0.0 0.0 0.0 0.0 #DIV/0!
AHQ 23 24
Growth (LY) Growth (2LY) Balance to Do TREND
BUDGET

#DIV/0! #DIV/0! 0.0 0.0

#DIV/0! #DIV/0! 0.0 0.0

#DIV/0! #DIV/0! 0.0 0.0

#DIV/0! #DIV/0! 0.0 0.0

#DIV/0! #DIV/0! 0.0 0.0

#DIV/0! #DIV/0! 0.0 0.0

#DIV/0! #DIV/0! 0.0 0.0

AHQ 23 24
Growth (LY) Growth (2LY) Balance to Do TREND
BUDGET
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
AHQ 23 24
Growth (LY) Growth (2LY) Balance to Do TREND
BUDGET
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0

AHQ 23 24
Growth (LY) Growth (2LY) Balance to Do TREND
BUDGET
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0

AHQ 23 24
Growth (LY) Growth (2LY) Balance to Do TREND
BUDGET
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0

AHQ 23 24
Growth (LY) Growth (2LY) Balance to Do TREND
BUDGET
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
AHQ 23 24
Growth (LY) Growth (2LY) Balance to Do TREND
BUDGET
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
#DIV/0! #DIV/0! 0.0 0
Actual
Actual Actual
+Fc Sales
Sale Sale
(Nov'20 (Nov'21
(Nov'22 to
to Oct'21) to Oct'22)
Oct'23)

0.0 0.0 0.0

0.0 0.0 0.0

0.0 0.0 0.0

0.0 0.0 0.0

0.0 0.0 0.0

0.0 0.0 0.0

0.0 0.0 0.0


0.0 0.0 0.0

0.0 0.0 0.0

0.0 ADD AMT IN 0.0

Actual Sale Actual Sale Actual +Fc Sa


0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
` 0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0

0.0 ADD AMT IN 0.0


Actual Sale Actual Sale Actual +Fc Sa
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0

0.0 ADD AMT IN 0.0

Actual Sale Actual Sale Actual +Fc Sa


0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0

0.0 ADD AMT IN 0.0

Actual Sale Actual Sale Actual +Fc Sa


0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0

0.0 ADD AMT IN 0.0

Actual Sale Actual Sale Actual +Fc Sa


0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0

0.0 ADD AMT IN 0.0


Actual Sale Actual Sale Actual +Fc Sa
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
0.0 0.0 0.0
AHQ 23
24

0.0

0.0

0.0

0.0

0.0

0.0

0.0
0.0

0.0

0.0

AHQ 23 24 PLAN
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
AHQ 23 24 PLAN
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0

AHQ 23 24 PLAN
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0

AHQ 23 24 PLAN
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0

AHQ 23 24 PLAN
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
AHQ 23 24 PLAN
0.0
0.0
0.0
0.0
0.0
0.0
0.0
NAME: ZONAL MANAGER NAME
TOTAL ALL HQ EXAMPLE DEL & RAJ ALL ZONE
ZONE NAME ZONE NAME ADD HERE
DATE : / / 2023

AUTOFILL DATA FORMULA ADDED SO DO NOT ADD HERE

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)

1 CRYSTAL HBsAg (No of tests) 0 0


2 SIGNAL HCV (No of tests) 0 0
SIGNAL HIV + HIV 3D + BLINK (No
3 In TEST of tests) 0 0
4 Crystal HIV ( No of Test) 0 0
5 Crystal HCV ( No of Test) 0 0
5 PARAHIT (No of tests) 0 0
6 BGT (In Rs.) 0 0
7 TB PPD (In Rs.) 0 0
In Rs.
8 TYPHOID (In Rs.) 0 0
9 RHEUMATOLOGY (In Rs.) 0 0

NAME: REGIONAL MANAGER NAME


REGION NAME : REGION NAME ADD HERE

DATE : / / 2023

AUTO FILL AFTER FILL HQ DATA

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)

1 CRYSTAL HBsAg (No of tests) 0 0


2 SIGNAL HCV (No of tests) 0 0
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests) 0 0
4 Crystal HIV ( No of Test) 0 0
5 Crystal HCV ( No of Test) 0 0
5 PARAHIT (No of tests) 0 0
6 BGT (In Rs.) 0 0
7 TB PPD (In Rs.) 0 0
RS
8 TYPHOID (In Rs.) 0 0
9 RHEUMATOLOGY (In Rs.) 0 0
NAME: PERSON NAME ADD HERE
HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)
NAME: PERSON NAME ADD HERE
HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: REGIONAL MANAGER NAME


REGION NAME : REGION NAME ADD HERE

DATE : / / 2023

AU

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests) 0 0
2 SIGNAL HCV (No of tests) 0 0
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests) 0 0
4 Crystal HIV ( No of Test) 0 0
5 Crystal HCV ( No of Test) 0 0
5 PARAHIT (No of tests) 0 0
6 BGT (In Rs.) 0 0
7 TB PPD (In Rs.) 0 0
RS
RS
8 TYPHOID (In Rs.) 0 0
9 RHEUMATOLOGY (In Rs.) 0 0

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)
NAME: PERSON NAME ADD HERE
HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: REGIONAL MANAGER NAME


REGION NAME : REGION NAME ADD HERE

DATE : / / 2023

AUTO FILL AFTER FILL HQ DATA

Budget Actual Sales


Sr No. 0 Marketing Grp
(Nov'22 to Oct'23) (Nov'22 to Sep'23)

1 CRYSTAL HBsAg (No of tests) 0 0


2 SIGNAL HCV (No of tests) 0 0
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests) 0 0
4 Crystal HIV ( No of Test) 0 0
5 Crystal HCV ( No of Test) 0 0
5 PARAHIT (No of tests) 0 0
6 BGT (In Rs.) 0 0
7 TB PPD (In Rs.) 0 0
RS
8 TYPHOID (In Rs.) 0 0
9 RHEUMATOLOGY (In Rs.) 0 0
NAME: PERSON NAME ADD HERE
HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)
NAME: PERSON NAME ADD HERE
HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: REGIONAL MANAGER NAME


REGION NAME : REGION NAME ADD HERE

DATE : / / 2023

AU

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests) 0 0
2 SIGNAL HCV (No of tests) 0 0
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests) 0 0
4 Crystal HIV ( No of Test) 0 0
5 Crystal HCV ( No of Test) 0 0
5 PARAHIT (No of tests) 0 0
6 BGT (In Rs.) 0 0
7 TB PPD (In Rs.) 0 0
RS
RS
8 TYPHOID (In Rs.) 0 0
9 RHEUMATOLOGY (In Rs.) 0 0

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)
NAME: PERSON NAME ADD HERE
HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: REGIONAL MANAGER NAME


REGION NAME : REGION NAME ADD HERE

DATE : / / 2023

AUTO FILL AFTER FILL HQ DATA

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)

1 CRYSTAL HBsAg (No of tests) 0 0


2 SIGNAL HCV (No of tests) 0 0
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests) 0 0
4 Crystal HIV ( No of Test) 0 0
5 Crystal HCV ( No of Test) 0 0
5 PARAHIT (No of tests) 0 0
6 BGT (In Rs.) 0 0
7 TB PPD (In Rs.) 0 0
RS
8 TYPHOID (In Rs.) 0 0
9 RHEUMATOLOGY (In Rs.) 0 0
NAME: PERSON NAME ADD HERE
HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)
NAME: PERSON NAME ADD HERE
HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
RS
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
TEST

5 PARAHIT (No of tests)


6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: REGIONAL MANAGER NAME


REGION NAME : REGION NAME ADD HERE

DATE : / / 2023

AU

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests) 0 0
2 SIGNAL HCV (No of tests) 0 0
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests) 0 0
4 Crystal HIV ( No of Test) 0 0
5 Crystal HCV ( No of Test) 0 0
5 PARAHIT (No of tests) 0 0
6 BGT (In Rs.) 0 0
RS
7 TB PPD (In Rs.) 0 0
RS
8 TYPHOID (In Rs.) 0 0
9 RHEUMATOLOGY (In Rs.) 0 0

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
RS
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
RS
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
RS
9 RHEUMATOLOGY (In Rs.)

NAME: PERSON NAME ADD HERE


HQ NAME : HQ NAME ADD HERE
REGION NAME : REGION NAME ADD HERE
DATE : / / 2023

Sr No. Marketing Grp Budget Actual Sales


(Nov'22 to Oct'23) (Nov'22 to Sep'23)
1 CRYSTAL HBsAg (No of tests)
2 SIGNAL HCV (No of tests)
SIGNAL HIV + HIV 3D + BLINK (No
3 TEST of tests)
4 Crystal HIV ( No of Test)
5 Crystal HCV ( No of Test)
5 PARAHIT (No of tests)
6 BGT (In Rs.)
7 TB PPD (In Rs.)
RS
8 TYPHOID (In Rs.)
9 RHEUMATOLOGY (In Rs.)
SO DO NOT ADD HERE
Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!

0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!

0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

AUTO FILL AFTER FILL HQ DATA


Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!

0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Forecasted Sales Actual + Fc Sales Actual Sale Actual Sale


% Achived
(Oct'23) (Nov'22 to Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)

0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!

0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

AUTO FILL AFTER FILL HQ DATA


Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!

0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!

0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

AUTO FILL AFTER FILL HQ DATA


Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!

0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!
0 0 0 0 #DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!

Actual + Fc Sales
Forecasted Sales Actual Sale Actual Sale
(Nov'22 to % Achived
(Oct'23) (Nov'21 to Oct'22) (Nov'20 to Oct'21)
Oct'23)
#DIV/0!
#DIV/0!

#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
#DIV/0!
CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23

#DIV/0! #DIV/0! 0.00 0 0 0


#DIV/0! #DIV/0! 0.00 0 0 0

#DIV/0! #DIV/0! 0.00 0 0 0


#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0

#DIV/0! #DIV/0! 0.00 0 0 0


#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
CUSTOMER ANALYSIS

CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS
CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0

#DIV/0! #DIV/0! 0.00 0 0 0


#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0

#DIV/0! #DIV/0! 0.00 0 0 0


#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
CUSTOMER ANALYSIS

CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS
CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0

#DIV/0! #DIV/0! 0.00 0 0 0


#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0

#DIV/0! #DIV/0! 0.00 0 0 0


#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
CUSTOMER ANALYSIS

CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS
CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0

#DIV/0! #DIV/0! 0.00 0 0 0


#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0
#DIV/0! #DIV/0! 0.00 0 0 0

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

CUSTOMER ANALYSIS CONVERSION

New Customer
Total no of Arkray L1
Growth (1Y) Growth (2Y) Balance to Do Acqu.
Users Customers
Nov22 to Sep'23
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00

#DIV/0! #DIV/0! 0.00


#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
#DIV/0! #DIV/0! 0.00
LOST

Customer Lost
Nov22 to Sep'23

0
0

0
0
0
0
0
0
0
0

LOST

Customer Lost
Nov22 to Sep'23

0
0

0
0
0
0
0
0
0
0
LOST

Customer Lost
Nov22 to Sep'23

LOST

Customer Lost
Nov22 to Sep'23
LOST

Customer Lost
Nov22 to Sep'23

LOST

Customer Lost
Nov22 to Sep'23
LOST

Customer Lost
Nov22 to Sep'23

LOST

Customer Lost
Nov22 to Sep'23
LOST

Customer Lost
Nov22 to Sep'23

LOST

Customer Lost
Nov22 to Sep'23

0
0

0
0
0
0
0
0
0
0

LOST

Customer Lost
Nov22 to Sep'23

LOST

Customer Lost
Nov22 to Sep'23
LOST

Customer Lost
Nov22 to Sep'23

LOST

Customer Lost
Nov22 to Sep'23
LOST

Customer Lost
Nov22 to Sep'23

LOST

Customer Lost
Nov22 to Sep'23
LOST

Customer Lost
Nov22 to Sep'23

LOST

Customer Lost
Nov22 to Sep'23

0
0

0
0
0
0
0
0
0
0
LOST

Customer Lost
Nov22 to Sep'23

LOST

Customer Lost
Nov22 to Sep'23
LOST

Customer Lost
Nov22 to Sep'23

LOST

Customer Lost
Nov22 to Sep'23
LOST

Customer Lost
Nov22 to Sep'23

LOST

Customer Lost
Nov22 to Sep'23
LOST

Customer Lost
Nov22 to Sep'23

LOST

Customer Lost
Nov22 to Sep'23

0
0

0
0
0
0
0
0
0
0

LOST

Customer Lost
Nov22 to Sep'23

LOST

Customer Lost
Nov22 to Sep'23
LOST

Customer Lost
Nov22 to Sep'23

LOST

Customer Lost
Nov22 to Sep'23
LOST

Customer Lost
Nov22 to Sep'23

LOST

Customer Lost
Nov22 to Sep'23
LOST

Customer Lost
Nov22 to Sep'23

LOST

Customer Lost
Nov22 to Sep'23

0
0

0
0
0
0
0
0
0
0
LOST

Customer Lost
Nov22 to Sep'23

LOST

Customer Lost
Nov22 to Sep'23
LOST

Customer Lost
Nov22 to Sep'23

LOST

Customer Lost
Nov22 to Sep'23
LOST

Customer Lost
Nov22 to Sep'23

LOST

Customer Lost
Nov22 to Sep'23
LOST

Customer Lost
Nov22 to Sep'23

LOST

Customer Lost
Nov22 to Sep'23

0
0

0
0
0
0
0
0
0
0

LOST

Customer Lost
Nov22 to Sep'23

LOST

Customer Lost
Nov22 to Sep'23
LOST

Customer Lost
Nov22 to Sep'23

LOST

Customer Lost
Nov22 to Sep'23
LOST

Customer Lost
Nov22 to Sep'23

LOST

Customer Lost
Nov22 to Sep'23
LOST

Customer Lost
Nov22 to Sep'23
PRESENTATION OF REVIEW MEETING
NAME: ZONAL MANAGER NAME
TOTAL ALL HQ : COUNT ADD HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

AUTOFILL AFTER FILLING HQ WISE UNDER EACH REGION

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)

Reagents (In Rs.)


Lipid A 0 0 0 0
Liver A 0 0 0 0
Metabolic A 0 0 0 0
Renal A 0 0 0 0
Cardiac A 0 0 0 0
Orinasys 0 0 0 0
Turbigold 0 0 0 0
Coagulation 0 0 0 0
Other Reagents 0 0 0 0
Instruments (In Qty)
Autochem Ingeniious 0 0 0 0
Ac Xact Pro 0 0 0 0
Autocell Plus 0 0 0 0
S-50 0 0 0 0
Thrombostat 0 0 0 0
U120 0 0 0 0
U 500 0 0 0 0
Spotchem EL 0 0 0 0
Pocketchem A1c 0 0 0 0
E-Plate 0 0 0 0
PA1c cartridges 0 0 0 0

NAME: REGIONAL MANAGER NAME


REGION NAME ADD REGION NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023
Sr Actual Sales Actual Sales
No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A 0 0 0 0
Liver A 0 0 0 0
Metabolic A 0 0 0 0
Renal A 0 0 0 0
Cardiac A 0 0 0 0
Orinasys 0 0 0 0
Turbigold 0 0 0 0
Coagulation 0 0 0 0
Other Reagents 0 0 0 0
Instruments (In Qty)
Autochem Ingeniious
0 0 0 0
Ac Xact Pro 0 0 0 0
Autocell Plus 0 0 0 0
S-50 0 0 0 0
Thrombostat 0 0 0 0
U120 0 0 0 0
U 500 0 0 0 0
Spotchem EL 0 0 0 0
Pocketchem A1c 0 0 0 0
E-Plate 0 0 0 0
PA1c cartridges 0 0 0 0

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A

Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges
NAME: PERSON NAME
HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro

Autocell Plus
S-50
Thrombostat
U120

U 500

Spotchem EL

Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold

Coagulation

Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents

Instruments (In Qty)


Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: REGIONAL MANAGER NAME


REGION NAME ADD REGION NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A 0 0 0 0
Liver A 0 0 0 0
Metabolic A 0 0 0 0
Renal A 0 0 0 0
Cardiac A 0 0 0 0
Orinasys 0 0 0 0
Turbigold 0 0 0 0
Coagulation 0 0 0 0
Other Reagents 0 0 0 0
Instruments (In Qty)
Autochem Ingeniious 0 0 0 0
Ac Xact Pro 0 0 0 0
Autocell Plus 0 0 0 0
S-50 0 0 0 0
Thrombostat 0 0 0 0
U120 0 0 0 0
U 500 0 0 0 0
Spotchem EL 0 0 0 0
Pocketchem A1c 0 0 0 0
E-Plate 0 0 0 0
PA1c cartridges 0 0 0 0
NAME: PERSON NAME
HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023
Sr Actual Sales Actual Sales
No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: REGIONAL MANAGER NAME


REGION NAME ADD REGION NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


Budget Actual Sales
No Marketing Grp (Nov'22 to (Nov'22 to
(Nov'22 to Oct'23) ( Oct'23)
. Sep'23) Oct'23)
Reagents (In Rs.)
Lipid A 0 0 0 0
Liver A 0 0 0 0
Metabolic A 0 0 0 0
Renal A 0 0 0 0
Cardiac A 0 0 0 0
Orinasys 0 0 0 0
Turbigold 0 0 0 0
Coagulation 0 0 0 0
Other Reagents 0 0 0 0
Instruments (In Qty)
Autochem Ingeniious
0 0 0 0
Ac Xact Pro 0 0 0 0
Autocell Plus 0 0 0 0
S-50 0 0 0 0
Thrombostat 0 0 0 0
U120 0 0 0 0
U 500 0 0 0 0
Spotchem EL 0 0 0 0
Pocketchem A1c 0 0 0 0
E-Plate 0 0 0 0
PA1c cartridges 0 0 0 0

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges
NAME: PERSON NAME
HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A

Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023
Sr Actual Sales Actual Sales
No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro

Autocell Plus
S-50
Thrombostat
U120

U 500

Spotchem EL

Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold

Coagulation

Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents

Instruments (In Qty)


Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: REGIONAL MANAGER NAME


REGION NAME ADD REGION NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023
Sr Actual Sales Actual Sales
No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A 0 0 0 0
Liver A 0 0 0 0
Metabolic A 0 0 0 0
Renal A 0 0 0 0
Cardiac A 0 0 0 0
Orinasys 0 0 0 0
Turbigold 0 0 0 0
Coagulation 0 0 0 0
Other Reagents 0 0 0 0
Instruments (In Qty)
Autochem Ingeniious 0 0 0 0
Ac Xact Pro 0 0 0 0
Autocell Plus 0 0 0 0
S-50 0 0 0 0
Thrombostat 0 0 0 0
U120 0 0 0 0
U 500 0 0 0 0
Spotchem EL 0 0 0 0
Pocketchem A1c 0 0 0 0
E-Plate 0 0 0 0
PA1c cartridges 0 0 0 0

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges
NAME: PERSON NAME
HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023
Sr Actual Sales Actual Sales
No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: REGIONAL MANAGER NAME


REGION NAME ADD REGION NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


Budget Actual Sales
No Marketing Grp (Nov'22 to (Nov'22 to
(Nov'22 to Oct'23) ( Oct'23)
. Sep'23) Oct'23)
Reagents (In Rs.)
Lipid A 0 0 0 0
Liver A 0 0 0 0
Metabolic A 0 0 0 0
Renal A 0 0 0 0
Cardiac A 0 0 0 0
Orinasys 0 0 0 0
Turbigold 0 0 0 0
Coagulation 0 0 0 0
Other Reagents 0 0 0 0
Instruments (In Qty)
Autochem Ingeniious
0 0 0 0
Ac Xact Pro 0 0 0 0
Autocell Plus 0 0 0 0
S-50 0 0 0 0
Thrombostat 0 0 0 0
U120 0 0 0 0
U 500 0 0 0 0
Spotchem EL 0 0 0 0
Pocketchem A1c 0 0 0 0
E-Plate 0 0 0 0
PA1c cartridges 0 0 0 0

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A

Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro

Autocell Plus
S-50
Thrombostat
U120

U 500

Spotchem EL

Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold

Coagulation

Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023
Sr Actual Sales Actual Sales
No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents

Instruments (In Qty)


Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: REGIONAL MANAGER NAME


REGION NAME ADD REGION NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A 0 0 0 0
Liver A 0 0 0 0
Metabolic A 0 0 0 0
Renal A 0 0 0 0
Cardiac A 0 0 0 0
Orinasys 0 0 0 0
Turbigold 0 0 0 0
Coagulation 0 0 0 0
Other Reagents 0 0 0 0
Instruments (In Qty)
Autochem Ingeniious 0 0 0 0
Ac Xact Pro 0 0 0 0
Autocell Plus 0 0 0 0
S-50 0 0 0 0
Thrombostat 0 0 0 0
U120 0 0 0 0
U 500 0 0 0 0
Spotchem EL 0 0 0 0
Pocketchem A1c 0 0 0 0
E-Plate 0 0 0 0
PA1c cartridges 0 0 0 0

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges

NAME: PERSON NAME


HQ NAME ADD HE NAME HERE
ZONE: ADD ZONE NAME
DATE : / / 2023

Sr Actual Sales Actual Sales


No Marketing Grp Budget Actual Sales
(Nov'22 (Nov'22
. (Nov'22 to Oct'23) ( Oct'23)
to Sep'23) to Oct'23)
Reagents (In Rs.)
Lipid A
Liver A
Metabolic A
Renal A
Cardiac A
Orinasys
Turbigold
Coagulation
Other Reagents
Instruments (In Qty)
Autochem Ingeniious
Ac Xact Pro
Autocell Plus
S-50
Thrombostat
U120
U 500
Spotchem EL
Pocketchem A1c
E-Plate
PA1c cartridges
Actual Sale Actual Sale
(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

0 0 #DIV/0! #DIV/0! #DIV/0!


0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!

0 0 #DIV/0! #DIV/0! #DIV/0!


0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
Actual Sale Actual Sale
(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)
Reagents (In Rs.)
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!

0 0 #DIV/0! #DIV/0! #DIV/0!


0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
Actual Sale Actual Sale
(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
Actual Sale Actual Sale
(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#REF! #DIV/0! #DIV/0!
#REF! #DIV/0! #DIV/0!
#REF! #DIV/0! #DIV/0!
#REF! #DIV/0! #DIV/0!
#REF! #DIV/0! #DIV/0!
#REF! #DIV/0! #DIV/0!

#REF! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

0 0 #DIV/0! #DIV/0! #DIV/0!


0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!

0 0 #DIV/0! #DIV/0! #DIV/0!


0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
Actual Sale Actual Sale
(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
Actual Sale Actual Sale
(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
Actual Sale Actual Sale
(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)
Reagents (In Rs.)
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!

0 0 #DIV/0! #DIV/0! #DIV/0!


0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
Actual Sale Actual Sale
(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
Actual Sale Actual Sale
(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#REF! #DIV/0! #DIV/0!
#REF! #DIV/0! #DIV/0!
#REF! #DIV/0! #DIV/0!
#REF! #DIV/0! #DIV/0!
#REF! #DIV/0! #DIV/0!
#REF! #DIV/0! #DIV/0!

#REF! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
Actual Sale Actual Sale
(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

0 0 #DIV/0! #DIV/0! #DIV/0!


0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!

0 0 #DIV/0! #DIV/0! #DIV/0!


0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
Actual Sale Actual Sale
(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
Actual Sale Actual Sale
(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)
Reagents (In Rs.)
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!

0 0 #DIV/0! #DIV/0! #DIV/0!


0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
Actual Sale Actual Sale
(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
Actual Sale Actual Sale
(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#REF! #DIV/0! #DIV/0!
#REF! #DIV/0! #DIV/0!
#REF! #DIV/0! #DIV/0!
#REF! #DIV/0! #DIV/0!
#REF! #DIV/0! #DIV/0!
#REF! #DIV/0! #DIV/0!

#REF! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

0 0 #DIV/0! #DIV/0! #DIV/0!


0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!

0 0 #DIV/0! #DIV/0! #DIV/0!


0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!
0 0 #DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
Actual Sale Actual Sale
(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

Actual Sale Actual Sale


(Nov'21 to (Nov'20 to % Achived Growth (1Y) Growth (2Y)
Oct'22) Oct'21)

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!

#DIV/0! #DIV/0! #DIV/0!


#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
#DIV/0! #DIV/0! #DIV/0!
CUSTOMER ANALYSIS
CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0

0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0

CUSTOMER ANALYSIS CONVERSION LOST


New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0

0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0

CUSTOMER ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

CUSTOMER ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0

0.0

0.0
0.0
0.0
0.0
CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

CUSTOMER CONVERSION LOST


ANALYSIS

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0

0.0

0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0

0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

CUSTOMER
ANALYSIS CONVERSION LOST
New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

CUSTOMER ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0

0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0

CUSTOMER ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
CUSTOMER ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0

0.0

0.0
0.0
0.0
0.0

CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

CUSTOMER CONVERSION LOST


ANALYSIS

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0

0.0

0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0

0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0

CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

CUSTOMER
ANALYSIS CONVERSION LOST
New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

CUSTOMER ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0

0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
CUSTOMER ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

CUSTOMER ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0

0.0

0.0
0.0
0.0
0.0

CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

CUSTOMER CONVERSION LOST


ANALYSIS

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0

0.0

0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

CUSTOMER
ANALYSIS CONVERSION LOST
New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0

0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0
0.0 0 0 0 0

CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

CUSTOMER
ANALYSIS CONVERSION LOST

New Customer
Customer Lost
Balance to Do Total no of Users L1 Customers Acqu.
Nov22 to Sep'23
Nov22 to Sep'23

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0

0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
"What Worked in
Terms Challenges
1) Region / Head Quarter

2) New Procedure Followed

3) Scheme Operated

4) New Distribution Channel

5) Division wise -Cog/PDP - Reagent / Inst

6) Focused Product

10 ) Manpower
"What Worked in Region"
Action Plnned Monitered Results
Remarks If any
"What didn't Work" in YO
Terms Challenges Action Plnned
1) Region / Head Quarter

2) New Procedure Followed

3) Scheme Operated

4) New Distribution Channel

5) Division wise -Cog/PDP - Reagent / Inst

6) Focused Product

10 ) Manpower
rk" in YOUR Region
Monitered Results Remarks If any
HQ S/N
HQ1 1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
HQ2 20
21
22
23
24
25
26
27
28

HQ3
29
HQ3 30
31
32
33
34
35
36
37
38
39
HQ4 40
41
42
43
44
45
46
47
48
HQ5 49
50
51
52
53
54
55
56
57
58
HQ6 59
60
61
62
63
64
65
66
67
68
HQ7 69
70
71
72
73
74
75
76
77
78
HQ8 79
80
81
82
83
84
85
86
87
88
89
HQ9 90
91
92
93
94
95
96
97
98
99
HQ10 100
CHALLENGE
Challenges
CHALLENGES & ACTION PLAN NO
Action Plane
ON PLAN NOV 22 to SEP 23
Monitoring
to SEP 23
Results Remark if any
HOME
RM Name
Region
NOV22 to SEP'23 HbA1c
Region Act Sale 20-21 Act Sale 21-22 Act Sale 22-23

20 ml 40 ml 20 ml 40 ml 20 ml

NOV22 to OCT'23 - Crystal HIV


Region Act Sale 20-21 Act Sale 21-22 Act Sale 22-23

NOV22 to OCT'23 - Crystal HCV


Region Act Sale 22-23

50 Test 25 Test Total CRY HCV


0

NOV22 to OCT'23 - Dengue


Region Act Sale 22-23

Duo Ns1 Total Duo+Ns1

0
NOV22 to SEP'23 HbA1c
Act Sale 22-23 21-22 22-23 Comments

40 ml Cust. Acquired Cust. Lost Cust. Acquired Cust. Lost

NOV22 to OCT'23 - Crystal HIV


Act Sale 22-23 21-22 22-23 Comments

Cust. Acquired Cust. Lost Cust. Acquired Cust. Lost

NOV22 to OCT'23 - Crystal HCV


Act Sale 22-23 22-23 Comments

Total CRY HCV Cust. Acquired Cust. Lost


0

NOV22 to OCT'23 - Dengue


Act Sale 22-23 22-23 Comments

Total Duo+Ns1 Cust. Acquired Cust. Lost

0
Customer Attributes Updates in SFA

H.Q. Total No. of Customers in SFA

HQ1 Name
HQ2 Name
HQ3 Name
HQ4 Name
HQ5 Name
HQ6 Name
HQ7 Name
HQ8 Name
HQ9 Name
HQ10 Name
Updates in SFA

Total No. of customers for whom Propsect traker


Attributes updated Senging or not
Customer
conversion
Uddated or not
ZONE - Strategy Result ( Impact on sales) / Next 6 month additional Sale Expectation if growth Factor used for long term

What Amount of Additional Business Expected Countinuw Growh Amt in Next 6


Strategy
Generated Month

DIVISION ZONE TERRITORY MKT GRP GROWN DEGROWN REMARK FOR GROWTH REMARK FOR DEGROWTH
KFAG - NOV22 TO SEPT23+OCT23 FC & OUTCOME

Cogent Reagents
PDP (Additinal sale of Instruments( Total
RM/AZM Focused HQ ( Additinal sale of
Hiv +Hbsag+ HCv in ) sale )
LFT+Turibi+RFT in )

KFAG PLAN FOR NOV23 TO FEB24 ( Next 4 Month )


AZM RM Focused HQ PDP Cogent Reagents
CLEARLY MENTION AS PER LAST MEET PLAN GIVEN WHAT YOU ACHIVED & WHAT IS YOUR NEXT 4 MONTH PLAN IN TABLE2 W

Action ("What" to achieve the


Opportunity/Issue Target/Goal
Target/Goal)

Instruments Opportunity/Issue Target/Goal


OUR NEXT 4 MONTH PLAN IN TABLE2 WITH SALE FIG.

Action Goal (Numerical)

Action ("What" to achieve the Target/Goal)


Achievemrnt

Action Goal (Numerical) Achieved Result


STRATEGY & IMPLEMENTATION FOR NE
Urine Sediment Analyser

Ingenious Out/DBT

Autochem

Xactpro

Autocell
U120

Thrombostat

SPOTCHEM EL

POCKETCHEM A1C
H.Q/Ex-H.Q/OS/
Salesperson Name HQ Towns Covered EX-OS
TCP FORMAT
Business/Month (Prev. Qtr
Number of Ave in Lac)
Distance in KMs Mode Of Transport Frequency of
From HQ to reach that town Visit working days
per month Instruments
ness/Month (Prev. Qtr Total Number of labs in that town ( including Active Accounts )
Ave in Lac)
Path Lab /
Reagents Tech Lab Blood banks Gyanec lab Hospital Labs
cluding Active Accounts ) Active Accounts (customers using our produc
Orthopedic Path Lab /
labs TOTAL Tech Lab Blood banks Gyanec lab
ts (customers using our product)
Orthopedic
Hospital Labs labs TOTAL
STRATEGY / ACTION PLAN FOR NO
Appointment
DIST APP TGT Achivement AP / L BIHAR / L DEL / L GUJ1 / L
Month
Nov22 2 0 0 0 0
Dec22 8 2 0 0 0
Jan23 10 0 0 1 0
Feb23 5 0 0 0 0
Mar23 6 0 0 1 0
Apr23 NOV TO OCT 23 9 1 0 1 1
May23 '100 DIST TGT 10 0 0 1 1
Jun23 0 0 0 0 0
Jul23 5 0 0 0 0
Aug23 3 0 0 0 0
Sep23 0 0 0 0 0
Oct23 0 0 0 0 0

100 Total Dist TGT


Grand Total 58 3 0 4 2
for Year22-23

DIST - ZONE TGT


5 5 5 5
BALANCE TARGET 2 5 1 3

NEW DIST APPOINTMENT TGT 22-23 ( NOV TO OCT ) 100 TGT


NEW DIST APPOINTED FROM NOV22 to AUG 23 58 ACHIVED

Min 3 or
Less than 1 Dist Min 1 Dist Min 2 Dist More than 3
LOSI OF ZONE
Appointed Appointed Appointed Dist
Appointed
AP / L 0 3
BIHAR / L 0 0 0
DEL / L 0 0 4
GUJ1 / L 0 2 0
KARN / L 4
KRL 1 / L 3
KRL 2 / L 0 5
MAH1 / L 0 3
MAH2 / L 2 0
MUM / L 1 0
MP / L 1 0
NE / L 2 0
RAJ / L 0 4
PJB / L 5
TELG / L 2 0
TN1 / L 2 0
TN2 / L 0 4
UP 1 / L 0
UP 2 / L 10
WB / L 1 0

TGT ACHIVMENT TGT ACHIVMENT


NEW DIST CURRENT
NEW DIST TGT
NEW DIST TGT 20- TGT 22-23 NEW DIST
( NOV TO
21 (NOV TO OCT) (NOV TO APP. NOV to
OCT)21-22
OCT) AUG 23
NEW DIST TGT 75 87 100 58
PER MONTH RATE 6.3 7.3 8.3 5.8
N PLAN FOR NOV22 TO OCT23 NEW DIST APPOINT -Result NOV22 TO AUG2
REGION NAME
KARN / L KRL 1 / L KRL 2 / L MAH1 / L MAH2 / L MUM / L MP / L NE / L RAJ / L PJB / L
0 0 0 0 0 0 0 0 1 0
0 0 0 0 0 1 0 0 0 3
0 2 2 1 1 0 0 1 0 1
0 0 0 1 1 0 0 0 1 0
0 0 2 0 0 0 0 0 2 0
0 0 0 1 0 0 0 1 0 0
0 0 1 0 0 0 0 0 0 1
0 0 0 0 0 0 0 0 0 0
3 0 0 0 0 0 1 0 0 0
1 1 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0

4 3 5 3 2 1 1 2 4 5

5 5 5 5 5 5 5 5 5 5

1 2 0 2 3 4 4 3 1 0
OV22 TO AUG23
TELG / L TN1 / L TN2 / L UP 1 / L UP 2 / L WB / L Grand Total
0 0 0 0 1 0 2
1 0 0 0 0 1 8
0 0 1 0 0 0 10
0 0 1 0 1 0 5
0 0 0 0 1 0 6
0 1 1 0 2 0 9
0 1 1 0 4 0 10
0 0 0 0 0 0 0
1 0 0 0 0 0 5
0 0 0 0 1 0 3
0 0 0 0 0 0 0
0 0 0 0 0 0 0

2 2 4 0 10 1 58

5 5 5 5 5 5
100
3 3 1 5 -5 4 42

You might also like